GL1X · GenesisL1 explorer

MolNFT v1 · #109989 · protein

Crystal structure of ERK2 in complex with an inhibitor 14K

4XJ0 · Mitogen-activated protein kinase 1: “Crystal structure of ERK2 in complex with an inhibitor 14K”. X-ray diffraction, 1 ligand (41B), 10 pockets (best druggability 0.80). MolNFT v1 #109989 on GenesisL1: 3D structure, binding sites…

PDB
4XJ0
Type
protein
Length
685 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase 1
EC
2.7.11.24
UniProt
P28482
Ligands
41B
Pockets
10 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 38% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase 1 (EC 2.7.11.24)protein34639% helix, 16% strandP28482
BMitogen-activated protein kinase 1 (EC 2.7.11.24)protein33937% helix, 15% strandP28482

Ligands and binding sites

  • 41B · 1-[(1S)-1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl]-4-[2-(tetrahydro-2H-pyran-4-ylamino)pyrimidin-4-yl]pyridin-2(1H)-one · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

10 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110190.800.819241B
24710.670.794041B
33120.550.7538empty
41310.480.7925empty
51280.460.7824empty

Interfaces

1 interface between chains.

  • A–B · 934 Ų buried · 14 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 modified (phosphorylation).

Compared structures

  • 4XJ0 · Crystal structure of ERK2 in complex with an inhibitor 14K · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.